Webinar: Open questions about nano and face masks

Face masks characterize the public spaces today. Together with other measures, such as social distancing, hand hygiene and contact tracing, masks actively contribute to fight the spread of COVID-19 until vaccines or drugs will be available to treat the disease.

Every crisis creates opportunities. In recent months, many Swiss SMEs have been thinking about what makes a good mask. They have scaled up networking, have been experimenting and tinkering and tried out different ways to develop a sustainable high-tech mask made in Switzerland.

But before a new protective mask can be launched on the market either as a respiratory protection mask (Filtering Facepiece mask or FFP) or a surgical mask, a whole series of tests must be run and certificates to guarantee its quality must be obtained. Protective masks containing nanomaterials in particular must meet the requirements of the EU Medical Devices Regulation of 2017.

Having received an increasing number of enquiries about nanoparticles and face masks, contactpointnano.ch has organized a webinar on Nano and masks.

Program

Sergio Bellucci: The national contactpointnano.ch

Peter Wick: Covid-19, face masks and how nanotechnology can provide solutions

Margrit Widmann:  Classification and regulation of protective masks

Wouter Pronk: Antiviral face masks: Industrial experience

Christoph Geers: The Swiss NanoAnalytics platform

Related articles

Webinar: Open questions a... Face masks characterize the public spaces today. Together with other measures, such as social distancing, hand hygiene and contact tracing, masks actively contribute to fight the spread
Safe-by-design and EU fun... Contribution of the EU NanoSafetyCluster (NSC), supporting the SbD-study of the European Commission, March 2021 Editors: Andreas Falk, Flemming R. Cassee and Eva Valsami-Jones
Subscribe to our newslett... Like to be kept up to date? Sign up to our bi-monthly newsletter here!
Publications on Synthetic... Action plan Synthetic Nanomaterials Final report 2 September 2020 (only available in German and French) Opportunities and Risks of Nanomaterials Journal of Nanobiotechnology, 2017 Opportunities and Risks
Questions about nanomater... New initiative to pool know-how on synthetic nanomaterials in Switzerland Hönggerberg, June 7, 2018 – At the Swiss Nano Convention 2018, taking place at ETH Zurich this
Clinam Summit in Basel This year, the 14th European and Global Summit for Clinical Nanomedicine (CLINAM Summit) organized by the European Foundation for Clinical Nanomedicine will take place on 8-11 October
Nanomedicine: The Minuten... Tiny particles that can fight cancer or that can easily pass through any interface within our body are a great promise for medicine. But there is little
Crucial results for coron... Empa researcher Peter Wick, Head of the Particles-Biology Interactions Laboratory in St. Gallen and Director of contactpointnano.ch talks to Empa Quarterly about recent antibody studies, which are
Swiss NanoConvention Dr. Peter Wick represented contactpointnano and Empa at the Swiss NanoConvention in Neuchâtel (June 15-16, 2023). This year, the topics included nanoimaging, advanced manufacturing at nanoscale, smart
Characterizing Nanopartic... Live Webinar, Thursday 19 November, 15:00 (Zürich). Guest speaker Dr. Sandor Balog, Details, Please register for this event using this link